Menopur

Menotropin, the active ingredient in Menopur, is a gonadotropin presented as an injectable solution for subcutaneous use. It treats infertility related to anovulation and is used in assisted reproductive protocols such as IVF. GNH USA supplies Menopur as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, fertility clinics and pharmacies worldwide.

Menopur, a gonadotropin used in reproductive medicine, is indicated for the following clinical situations: - Infertility due to anovulation: stimulates follicular development to enable ovulation in women who do not ovulate spontaneously. - Controlled ovarian stimulation for in‑vitro fertilization (IVF): supports multiple follicle growth to increase oocyte retrieval for IVF cycles. - Assisted reproductive technology (ART) protocols: provides FSH and LH activity required in various ART treatment regimens.

Menopur may cause a range of adverse reactions, which are generally related to its hormonal activity and the injection process.

Common Side Effects: - Injection site reactions: pain, redness, or swelling at the injection site. - Abdominal discomfort: mild bloating or cramping. - Headache: transient headache episodes.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (OHSS): severe fluid accumulation, rapid weight gain, and respiratory distress. - Multiple pregnancy: increased risk of twins or higher‑order gestations. - Allergic reactions: rash, urticaria, or anaphylaxis.

When using Menopur, clinicians should observe several safety considerations: - Dose individualization: dosing is individualized based on ovarian response monitoring. - Monitoring for OHSS: patients should be observed for signs of ovarian hyperstimulation syndrome. - Contraindications: not for use in women with uncontrolled thyroid disease, ovarian cysts, or hormone‑dependent tumors. - Pregnancy considerations: avoid use during established pregnancy. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medications; awareness of major and moderate interactions helps ensure safe use.

Major Interactions (Avoid): - GnRH antagonists: may reduce efficacy of Menotropin. - Aromatase inhibitors: concurrent use can alter estrogen feedback. - High‑dose estrogen therapy: may blunt ovarian response.

Moderate Interactions (Monitor Closely): - Anticoagulants: increased risk of bleeding with ovarian cyst rupture. - Corticosteroids: may affect hormone metabolism. - Thyroid hormone replacement: monitor thyroid function during treatment.